Conferences
EAU 2024: Controversies in Initial Staging for Bladder Cancer: TURBT Is Mandatory Before Any Treatment
April 5, 2024
EAU 2024: The PSMA M1a Positive Patient: Treat as M0
April 5, 2024
SESAUA 2024: Time Interval Between Radium-223 Therapy and 177Lu-PSMA Treatment for mCRPC and Outcomes in the RALU Study
March 25, 2024
SESAUA 2024: Screening with PSA and MRI: Yearly Trends by PI-RADS and Race Shows Stable Diagnosis of NCCN Very Low Risk Disease
March 23, 2024
SESAUA 2024: Non-Narcotic Compliance and Clinical Outcomes in ERAS Cystectomy Patients
March 22, 2024
SESAUA 2024: Skeletal Muscle Changes in Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy
March 22, 2024
SESAUA 2024: Determining the Genetic Causes of Bladder Cancer in a Family with Heritable Pattern of Bladder Cancer
March 22, 2024
SESAUA 2024: Intravascular Heparinization During IVC Thrombectomy and Perioperative Complications
March 21, 2024